Loading
DanCann Pharma
Dancann Pharma A/S operates as a biotechnology company. The Company focuses on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas. Dancann Pharma serves patients in Sweden.
Funding
Every round, secondary, debt facility or acquisition involving DanCann Pharma that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—